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ABSTRACT
Unexpected Dramatic Change in Psychotherapy:
Comparing Three Methods
Joseph Horner
Department of Psychology, BYU
Doctor of Philosophy
Unexpected dramatic changes in psychotherapy have been observed historically and tied
to high recovery rates. Many different methodologies that identify these changes are assumed to
be capturing similar or identical phenomena. This study compared three methods – Sudden
Gains (SG), Percentage Increase – 50% (PI-50), and Rapid Response (RR) - in a large database
looking for similarities and differences. Results suggest that there are significant differences
between SG, RR, and PI-50 as methods for operationally defining unexpected dramatic treatment
response, and caution should be used when referring to SG, PI-50, and RR as the same
phenomenon or interchangeable terms for unexpected dramatic treatment response. In particular,
overlap in clients who experienced both a SG and RR was low. Experiencing any of the three
phenomenon was associated with higher recovery rates, while differences abound in both which
clients experience each of the phenomena and demographic characteristics of those clients. PI50 identified inconsequential amounts of clients suggesting under its current methodological
construction it would have limited useability. These results tying SG, RR, and PI-50 to
significant rates of recovery and positive treatment change suggest possible future use as a
predictive feedback tool for clients and clinicians alike to be better able to examine the
effectiveness of treatment components during treatment.

Keywords: psychotherapy, psychotherapy outcome, sudden gains, rapid response, outcome
measurement, treatment response, course of treatment
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Unexpected Dramatic Change in Psychotherapy: Comparing Three Methods
For better and worse, the progress of clients in psychotherapy was and sometimes still
has been assumed to be linear in nature and fairly similar among clients. In reality, it is likely
that many different courses of progress are present, even among similar disorders, similar clients,
and similar psychotherapies. Lutz and colleagues (Lutz et al., 2013; Lutz et al., 2005; Lutz,
Stulz, & Köck, 2009) have found a subset of patients who change (a) positively and rapidly, (b)
positively and steadily, (c) remain the same, and (d) who show a deteriorating course. These
patterns of change have been used for clinical decision making and prediction of final outcome
(Newnham & Page, 2010). In the case of deterioration, predictive methods have been used to
identify treatment failure before it occurs and provide alarm signals that assist therapists in their
attempts to improve psychotherapy outcomes (Shimokawa, Lambert, & Smart, 2010). On the
other hand, observed dramatic, early, and rapid change patterns have implications for theories of
change, because many clients improve before they have received a significant amount of
treatment (Ilardi & Craighead, 1994) and a phenomena of unexpected dramatic treatment
response patterns were beginning to be defined in the literature.
Early work using rudimentary measures of unexpected dramatic treatment response such
as a ≥ 50% change in depressive symptomology from intake levels by session two (Renaud et
al., 1998) and significant response within the first two weeks of treatment, predicted better
outcomes at the end of treatment (Fennell & Teasdale, 1987) and even at up to 24 month followup (Renaud et al., 1998) when compared to patients not manifesting this phenomena. However,
the mechanisms, definition, and even what to label these phenomena has varied from study to
study. Labels used have included “Sudden Gains” (Tang & DeRubeis, 1999b), “Rapid
Response” (Fennell & Teasdale, 1987), “Early Response” (Ilardi & Craighead, 1994), “Large
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Sudden Improvements” (Gaynor et al., 2003), and “Early Sudden Gains” (Stiles et al., 2003).
Consequently, clarification is needed to understand if the operational definitions used by various
researchers are capturing the same phenomena. Parsimony in terms, however, can only be
obtained if the phenomena being studied are truly similar. The following will review operational
definitions of three phenomena and their criteria used to operationalize the stated phenomenon of
dramatic unexpected change in psychotherapy. In addition to capturing unexpected dramatic
change, each of the three phenomena may provide potential prediction tools for clinicians to
identify clients who may recover at higher rates than the general client population.
Percentage Improvement
A common criterion used early in the study of this phenomenon is a greater than or equal
to 50% reduction in score on an outcome measure. Used originally with the Beck Depression
Inventory (BDI) (Beck & Steer, 1987; Beck, Steer, & Brown, 1996), this criterion called for
examining cases where a “decline of ≥ 50% in the BDI score from pretreatment until the
beginning of the 2nd session of psychotherapy.” While psychopharmacology research often uses
this method, it has been used sparingly in psychotherapy studies. In a classic study, adolescents
who met this criterion showed better outcomes at the end of treatment and at 1 and 2 year followup periods (Renaud et al., 1998).
More recent iterations of this method have referred to these phenomenon as Percentage
Improvement 50% (PI-50). The PI-50 method compares change based on a baseline rate of
distress. In other words, if a 50% change in a measure of psychopathology is seen between the
initial score and the measure’s cutoff for clinically distressed or impaired, the client has
experienced the PI-50 phenomenon. Only a few recent studies utilized the PI-50 method for
change with psychotherapy (Dimidjian et al., 2006; Strauman et al., 2006). A recent study by
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Hiller, Schindler, and Lambert (2012) demonstrated comparable accuracy in showing clinically
significant change between the PI-50 method the Reliable Change Index (discussed below).
However, the PI-50 method, with one notable exception (Renaud et al., 1998), was historically
used with end of treatment scores and may require more research before being used as a
predictive method during treatment. Nevertheless, due to its simplicity in measurement and wide
use for other functions, the PI-50 method may show promise for use in a predictive function and
identification of unexpected dramatic treatment response in clients.
Sudden Gains
Spurred on by the work of Ilardi and Craighead (1994), researchers Tang and DeRubeis
(1999a) reconsidered the idea of dramatic “between session” changes (although in actuality the
change could have occurred during the session) in depression symptomology. Their initial study
(Tang & DeRubeis, 1999b) led to subsequent research, especially in the CBT treatment
literature. In their study they first offered a precise conceptual definition of the Sudden Gains
phenomena. They then operationalized this definition into the methodological form that is
largely used today. In their results they found many aspects of the Sudden Gains phenomena
which continued to be supported in subsequent research. The theoretical definition of Sudden
Gains was originally split into three requirements. Sudden gains were originally defined as the
intersession change needing to be “large (a) in absolute terms, (b) relative to depressive symptom
severity before the gain, and (c) relative to symptom fluctuations preceding and following the
gain” (Tang & DeRubeis, 1999b). The research was initially done using the Beck Depression
Inventory (Beck & Steer, 1987) or BDI as the outcome measure. This was later translated into
methodological terms stating that a Sudden Gain occurred when:
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the gain was (a) ≥ 7 BDI points (absolute magnitude), (b) represented at least 25% of
the pregain session’s BDI score (relative magnitude), and (c) the difference between
the mean BDI score of the three sessions before the gain (n - 2, n - 1, and n) and the
three sessions after the gain (n + 1, n + 2, and n + 3) was at least 2.78 times greater
than the pooled standard deviations of these sessions’ BDI scores (relative to
symptom fluctuation (Tang, DeRubeis, Hollon, Amsterdam, & Shelton, 2007).

This definition, while specific and replicable, is not without controversy. The criteria are
somewhat arbitrary in nature (e.g., 7 point change), but have been used to some degree in most
of the succeeding studies to some degree. Problems include the need for consecutive data of at
least 6 sessions. Such data is not always available, particularly in routine care. Measures other
than the BDI have been used to track client change in patients with depression, and disorders
other than depression are frequently studied where the Sudden Gains phenomenon is observed.
Frequency and outcomes. Sudden Gains based on the Tang et al., criteria were found
in 39% of the clients in the aforementioned study (Tang & DeRubeis, 1999b). Those who
experienced a Sudden Gain showed an average of 11.2 points of change on the BDI. This
change accounted for 51% of the total change of these clients by the end of 12-14 weeks of a
RCT cognitive therapy treatment. Of those who experienced Sudden Gains, 79% reached the
status of “recovered” by the end of treatment compared to 41% in those who did not experience a
Sudden Gain. At follow-up of 6 months and 18 months after the end of treatment, those who
experienced a Sudden Gain exhibited significantly reduced amounts of depressive symptoms on
the BDI, compared to those who had not experienced a Sudden Gain (Tang & DeRubeis, 1999b).
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Follow-up studies were conducted using much of the same criteria as the original criteria
for Sudden Gains (Tang & DeRubeis, 1999b). The studies available for review (Andrusyna,
2008; Andrusyna, Luborsky, Pham, & Tang, 2006; Cavallini & Spangler, 2013; Gaynor et al.,
2003; Hardy et al., 2005; Hofmann, Schulz, Meuret, Moscovitch, & Suvak, 2006; Lutz et al.,
2013; Stiles et al., 2003; Tang & DeRubeis, 1999b; Tang, DeRubeis, Beberman, & Pham, 2005;
Tang et al., 2007; Tang, Luborsky, & Andrusyna, 2002; Vittengl, Clark, & Jarrett, 2005)
exhibited results and outcomes similar to those in the original study.
Prediction of better outcomes. In all of the studies mentioned, the presence of Sudden
Gains was associated with better outcomes at the end of treatment. Multiple studies showed
significant maintenance of treatment gains at some period of follow-up (Gaynor et al., 2003;
Hardy et al., 2005; Stiles et al., 2003; Tang & DeRubeis, 1999b; Tang et al., 2007). Some
studies, however, did not show gains at follow-up relative to the rest of the sample (Hofmann et
al., 2006; Tang et al., 2002; Vittengl et al., 2005). Overall, a large amount of consistency in
results was seen across Sudden Gains studies. This suggests that this phenomenon can be largely
replicated by the use of the original methodological definition, despite its inherent statistically
arbitrary nature (Andrusyna et al., 2006; Tang & DeRubeis, 1999b; Tang et al., 2007).
A recent meta-analysis was published estimating the effects of Sudden Gains (Aderka,
Nickerson, Bøe, & Hofmann, 2012). They selected 16 studies with a total 1,104 participants. In
their results they found a robust moderate effect at post-treatment (Hedges’ g = 0.75) and followup (Hedges’ g = 0.56) for those who experienced a SG. As such, in this study SG are associated
with moderate, short, and long term improvements in depression and anxiety symptoms. They
also analyzed treatment orientation as a moderating effect, and found the effect size tended to be
higher in CBT studies compared to other methods when treating depression and anxiety
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(Hedges’ g = 0.75 for CBT vs Hedges’ g = 0.23 for other treatments). This may be explained by
the high degree of control in many of the CBT studies when compared to their non-CBT
counterparts. It may also be evidence of CBT’s tendency to cause Sudden Gains to occur.
Unfortunately when theorizing how to explain Sudden Gains, this article shows considerable bias
towards cognitive methods in the studies included, but nevertheless serves to illustrate the
accumulating interest in the topic of treatment components. Indeed, the fact that SG occur in one
intercession period that can follow a specific treatment component lends natural interest in this
area.
Rapid Response to Psychotherapy
Spurred on by research contrasting the placebo effect in psychotropic anti-depressant
medications and psychotherapy and the Sudden Gains literature, Haas, Hill, Lambert, and
Morrell (2002) investigated the timing of dramatic response in psychotherapy and its relation to
reported psychological distress at the end of treatment and at follow-up. Often in studies with
anti-depressant medication, rapid response to treatment was a negative indicator for long-term
outcomes following administration of psychoactive medications. In psychotherapy research
indications of the opposite have been found to be true. Individuals from a counseling center at a
private university whose mental health had been tracked over the course of their psychotherapy
treatment were sent the Outcome Questionnaire-45 OQ-45: (Lambert, Kahler, Harmon,
Shimokowa, & Burlingame, 2011) one to two years after the discontinuation of treatment to
measure treatment outcome at follow-up. Of the 240 returned surveys, 61% had attended at least
one session of psychotherapy, and had intake OQ-45 scores in a distressed range.
Clients were selected as having experienced a Rapid Response to psychotherapy when
their OQ-45 scores following their first three sessions of treatment were significantly lower (10th
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percentile) than predicted scores based on statistical modeling of treatment response from a
large sample of outpatients whose response to treatment was tracked on a weekly basis (Finch,
Lambert, & Schaalje, 2001). Expected treatment response is based on deviations from patients
with identical (or nearly identical) level of initial disturbance. The use of scores averaged across
the first three sessions was a judgment call of the researchers in an attempt to best capture
response as “rapid” (i.e., early) and stable. Clients’ were categorized at treatment termination
and follow-up as “improved” if the change in OQ-45 score decreased and met criterion equal to,
or larger than, the reliable change index of the OQ-45 or as “recovered” if their OQ-45 score
changed reliably and dropped below clinical levels of dysfunction.
Analyzing the data, the researchers found that those with more dramatic rates of response
had better outcomes at termination and follow-up (Haas et al., 2002). Of the rapid responders,
84% were categorized as improved or recovered by the end of treatment. This made up 82% of
all reliably improved cases and 61% of all recovered cases in the sample were unexpected
dramatic responders. Maintenance of gains at follow-up was also shown in clients classified as
rapid responders to psychotherapy.
Subsequent research. A related follow-up study by Lutz et al. (2009) confirmed a
correlation between Rapid Response and outcome in treatment. In their study, all participants
who experienced Rapid Response had significant change at the end of treatment. Further, 96%
of their sample maintained these gains at follow-up. Both at the end of treatment and follow-up,
the Rapid Response group outperformed the rest of the sample (Lutz et al., 2009).
The Necessity of “Early”
As stated earlier, many have speculated that this phenomenon of dramatic unexpected
change in psychotherapy often occurs early in treatment (Andrusyna, 2008; Flückiger, Holtforth,
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Znoj, Caspar, & Wampold, 2013; Haas et al., 2002; Tang et al., 2007; Van et al., 2008). For
example, in CBT literature, it has been suggested that as much as 60-70% of gains are made in
the first four weeks (Ilardi & Craighead, 1994). Often unexpected dramatic change occurs
before it is plausible to attribute the change to the supposed mechanisms of the treatment being
used (Lambert, 2005). Many of the Sudden Gains studies reviewed above showed the median
session of occurrence to be session five. Of note in one study (Tang et al., 2007), looking at a
data set with two different Sudden Gains criteria, a slight modification disallowing identification
of Sudden Gains before session five of treatment, among other changes, seemed to eliminate the
presence of Sudden Gains association with outcome in that particular study. Likewise, in the
reference study for Rapid Response the clients were only labeled as having experienced a Rapid
Response to psychotherapy if it occurred in the first three sessions of treatment (Haas et al.,
2002), a claim that has seen other support in naturalistic treatment settings (Delgadillo et al.,
2014). A study by Busch, Kanter, Landes, and Kohlenberg (2006) found that of those who
experienced Sudden Gains, experienced them in the first half of treatment and had significantly
better outcomes at the end of treatment than those who did not have a Sudden Gain over this
same time period. Those who had experienced Sudden Gains in the last half of treatment
showed no such differences. In Stiles et al. (2003), no significant relationship to outcome was
seen in those who experienced a Sudden Gain after session 16 in a naturalistic sample.
These studies offer evidence that the occurrence of Sudden Gains or Rapid Response to
psychotherapy may be more meaningful when they occur early in the course of therapy and
before many of the specific therapeutic techniques, such as the challenging automatic thoughts
portion of many CBT protocols, had been offered (Busch et al., 2006). However, in the Sudden
Gains literature there is little consensus of how many sessions constitutes an operationalization
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of “early”. A range of cutoff scores are observed that vary from session five (Tang et al., 2007)
to session 16 (Stiles et al., 2003), to throughout therapy (Tang & DeRubeis, 1999b). Timing of
Sudden Gains even vary significantly in the same study. Looking at CBT treatment for eating
disorders, Cavallini and Spangler (2013) observed that 50% of SG were experienced between
sessions 3 and 11 on an outcome measure for eating behaviors; and between sessions 5 and 15 on
an outcome measure for body image concerns. Due to this variability, most studies still include
and state all Sudden Gains that occur throughout treatment as it relates to ultimate outcome and
other variables whereas Rapid Response studies historically examine RR much earlier in
treatment.
RCT Versus Naturalistic ITT Studies
It should be noted that sudden gains have mainly been studied in randomized clinical
trials (RCTs) with set doses of therapy of about 12-14 sessions rather than in routine care where
doses are not set and treatments are of both longer and shorter duration.
In RCTs it is common that to participate in the study the patient has to agree to complete
either all or a high percentage of the treatment. If this does not happen, it is likely that the
patient and their results are excluded from the study. This data is excluded with no knowledge
on why the patient decided to no longer participate and if it related to being a subject in the
study. This is a logical part of a controlled study endeavoring to find if therapy has an effect, but
may not represent how psychotherapy is conducted in a naturalistic practice setting. As such,
one may conjecture if early dropouts are excluded in the RCT studies, a relatively large number
of Sudden Gains or Rapid Response to psychotherapy phenomena may be excluded. Conflicting
evidence to this effect is seen in the research literature. Haas et al. (2002) used a naturalistic
university counseling center database for their work. The therapy did not have a fixed dosage
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and generally did not last as long as a clinical trial. They observed a higher percentage of clients
with dramatic change than the average Sudden Gains study. In contrast, Stiles et al. (2003), who
also studied outcomes in a naturalistic practice, found a much lower percentage of patients
experienced Sudden Gains than in the average RCT Sudden Gains study.
Another difference found between naturalistic or intent-to-treat and RCT studies is the
control of the treatment administered. Whereas in most RCT studies treatments are tightly
controlled, naturalistic studies often endeavor to have clinicians operate in the manner in which
routine care is administered. As such, it is common for a whole host of different treatment
theoretical orientations to be used in naturalistic studies. Further, the pace, implementation, and
components of even similarly named treatments likely vary from practitioner to practitioner.
This study examined Sudden Gains in a “real world” or routine care setting. Admittedly, it is not
known whether the differences seen between RCT and ITT studies occur due to the inclusion of
patients that would be excluded from RCT studies, the uncontrolled nature of the treatments
implemented, or some other factor associated with studies in a naturalistic setting. Nevertheless,
it is an important factor to be aware of and consider when making assertions in this area of
research and especially relevant to the use of these different phenomena as feedback tools for
clinicians.
Predictive Tools
Predictive tools have become more commonly pursued by researchers in an effort to give
clinicians predictions of treatment outcome (Newnham & Page, 2010). Rapid Response,
Percentage Increase – 50%, and Sudden Gains phenomena can be calculated and identified
during the course of treatment easily by hand or by being built into the software of the measure
being used to track treatment progress. The need for a predictive tool may be necessary due to
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human error in identifying such clients by clinicians in real time. For example, in one study
(Davies et al., 2006) clinicians in routine clinical practice were only able to retroactively identify
half of the clients who had experienced a SG. Additionally, Flückiger et al. (2013) suggests
many different variable may need to be monitored early in therapy in addition to unexpected
dramatic response. As such, predictive tools may be helpful in this area.
Summary
As it turns out, psychotherapy does not appear to have incremental, session-by-session
effects over its course for all patients, but instead, patients who show a substantial benefit and
maintain these gains tend to respond rather unexpectedly and dramatically. Research has yet to
show why this is the case, but it is obvious that such changes precede rather than follow many of
the techniques thought necessary to bring about change.
There are also a variety of ways of operationally defining the dramatic, unexpected
change in psychotherapy phenomenon, but little agreement on methods to do so. Given the
research just reviewed, the general purpose of the current study was to explore three different
methods (operational definitions) of defining the phenomena of unexpected dramatic change
during psychotherapy using the same set of clients. The Sudden Gains method focuses on a
relatively large and absolute (set) amount of change at a single intersession period (relative to
initial disturbance and surrounding sessions). The Percentage Increase – 50% method relies on
the arbitrary cutoff of half of the clinical scale being used to measure treatment change. The
Rapid Response method depends on a positive change that is somewhat rare (experienced by
only 10% of cases at any particular session) relative to the changes made by the typical patient at
the same session of care who started with the same measured distress level. The identification of
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unexpected dramatic treatment response before termination using one of these methods may
benefit clinicians and clients alike in addition to having implications for theory.
Research Questions
Many of the outcomes related to Percentage Increase – 50%, Sudden Gains and Rapid
Response phenomena are similar. This may suggest, as stated earlier, that the phenomena being
studied may be in some part correlated or overlapping and that their operational differences may
be able to be used interchangeably. However, to make this assumption, one would assume
similarity between those identified as having experienced each of these three phenomena. If
these phenomena are in actuality different we would see differences in who experiences them
and in other variables related to treatment outcome. To gain a more complete understanding the
following questions were addressed in this study.
1. When using the separate historically defined criteria for Percentage Increase – 50%
(Renaud et al., 1998), Sudden Gains (Tang & DeRubeis, 1999b) and Rapid Response
(Haas et al., 2002), how much overlap in clients are identified between methods?
2. Do descriptive characteristics such as outcomes at the end of treatment, dosage
amounts, and other characteristics differ significantly between those in the sample
who experienced a Percentage Increase – 50%, Sudden Gains or Rapid Response
criteria?
Method
Participants
Clients were recruited from the BYU Counseling Center archival database. Those
seeking only academic services were excluded. Clients provided at least two measurements (one
inter-session period) where an OQ-45 measurement was taken. In addition, all clients included
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began treatment in the clinically distressed range of the OQ-45. Those included in the database
were university students who received individual psychotherapy between 1996 and 2013 and had
completed treatment by March 2013.
Therapy at the BYU counseling center is offered free of charge and without session limits
to full-time students of the university. Clients are referred or self-referred for a wide range of
problems, the majority of which are adjustment, anxiety or depression related. Individual
therapy generally consisted of the traditional 50 minute hour. All therapists were either PhD
level psychologists, psychologist trainees, or licensed clinical social workers. Therapy
theoretical system and implementation were used at the discretion of the therapist including
cognitive-behavioral, psychodynamic, client-centered, existential, systems, and integrative
modalities.
All clients used in the study completed treatment prior to data analysis. Prior approval
from the research committee overseeing the database was obtained following approval of the
Institutional Review Board. All clients routinely take the OQ-45 at each therapy session. The
OQ-45 was administered in the current study either by paper or electronically to patients prior to
the beginning of each therapy session, thus providing a measure of mental health functioning for
the week preceding each session attended. Clients and therapists were aware that outcome
scores were stored for research purposes, and informed consent was obtained at intake.
Outcome Measure
Psychological outcome was assessed during treatment using the Outcome Questionnaire45 (OQ-45) by Lambert et al. (2011) which is a 45-item instrument designed to measure client
distress and functioning over the last week and typically administered prior to each therapy
session to track progress in therapy. Items are rated on a 5-point Likert scale. Total scores can
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range from 0 to 180, with higher scores reflecting more severe distress and lower scores
reflecting less distress. It contains items to assess risk for suicide, substance abuse, and violence
at work. It has three domains: a depression and anxiety loaded symptom distress domain, a
domain reporting interpersonal functioning of the individual, and a domain concerning the
individual’s reported social roles. Its main use in this study was to track change of general
distress levels in these areas over time. It has a reported alpha level of .92. It has a correlation of
.63 with the Beck Depression Inventory (Lambert et al., 1996; Lambert et al., 2011). Test-retest
reliability was reported as .84 over a 3-week period. The OQ-45 is also reported, however, as
sensitive to change, improving an average of 17.47 points in a sample of 40 patients receiving
psychotherapy. Norms have been established for individuals between the ages of 18 and 80
within university, private practice, community mental health, outpatient, and inpatient settings.
Scores on the OQ-45 greater than or equal to 64 are considered in the clinical range (Lambert et
al., 2011).
Although OQ-45 scores can be explored as a continuous variable, the measure also offers
cut-offs for a reliable change index (RC) and clinically significant change (CS), derived from the
model of statistically operationalized clinically significant change proposed by Jacobson and
Truax (1991). RC is defined as change in observed scores that exceeds the amount of variation
expected within the standard error of measurement, which, in the case of the OQ-45, equals at
least 14 points. CS is distinguished by two criteria: a) the change observed is equal to or exceeds
the RC index, and b) the score leaves the clinical range of functioning (in the case of the OQ-45,
scores > 63) and enters the normal range of functioning (OQ-45 ≤ 63). Both RC and CS were
used in the current study to identify clinically significant change. Additionally, a change of 14
points in a negative direction (where the client is worse than when they began) defines reliable
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deterioration, another category explored for significant differences between groups. These
categories (i.e., RC, CS, and deterioration) are non-overlapping, and a significant portion of
clients experienced neither reliable change nor reliable deterioration.
Identification
Clients from the database were identified for each of the phenomena based on the following
criteria:
50% Percentage Increase (PI-50). The criteria for PI-50 phenomenon was taken from a
previous study where the PI-50 phenomena was used (Hiller et al., 2012) in order to keep in line
with literature on the topic and best represent historical operationalization of the phenomena.
This resulted in two criteria as necessary for a client to have experienced a PI-50:
1) The measured amount of change between beginning and OQ-45 at the session
examined was greater than 50% of the difference between the beginning OQ-45 score
and the basal OQ-45 score to qualify as clinically distressed (OQ ≥ 64). In other
words, if the change in a client’s OQ-45 score was greater than or equal to a 50%
change between the initial score and the measure’s cutoff for clinically distressed or
impaired. For example, if client A started treatment at an OQ-45 score of 104 and
then by session two reduced his OQ-45 score more than half the distance between his
initial score (104) and the cutoff for clinically distressed (64), or in this case 20 points
reduction on the OQ-45, that client would meet this criterion.
2) The total amount of change was equal to or greater than 25% of the entire range of
the instrument, which would be 45 points on the OQ-45. This criterion was proposed
by Hiller et al. (2012) to eliminate clients who may qualify for the first criterion
despite a low amount of change due to an initial OQ-45 score near the clinically
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distressed cutoff of 64. For example, if Client B started treatment at an OQ-45 score
of 70 and was measured as a score of 60 on session two that client would technically
meet criterion 1 (≥ 50% reduction in OQ-45 score) but not meet criterion 2’s
requirement of a 25% reduction over the entire range of the OQ-45.
In addition, while PI-50 criteria is often used as a total change measurement at the end of
treatment, in this study it is being used as a method of identifying unexpected dramatic treatment
response during treatment. A historical study by Renaud et al. (1998) used PI-50 to identify
those who changed early and in greater amounts than expected and its correlation to final
outcome and follow-up maintenance. They operationalized “early” as PI-50 occurring in the first
two sessions, an admittedly arbitrary number. It was decided to expand the criterion to the first
three sessions to be in line with the more extensive literature on Rapid Response (discussed
below). This decision is supported both by recent research suggesting three sessions as a cutoff
point (Delgadillo et al., 2014) and an analysis we conducted using different possible cut-off
points for the OQ-45. The analyses examined PI-50 using cutoffs of 2, 3, 4, and 5 sessions.
There was limited added value beyond that observed at session 3. Specifically, little difference
in mean number of weeks in therapy, initial distress levels, and ending distress levels was seen
after that point. As such, to keep in line with cutoff scores for RR (see below), past literature,
recent studies, as well as the current analysis, those who experienced a PI-50 at session 3 or
sooner were examined in this analysis.
Sudden Gains (SG). The criteria for identifying Sudden Gains have changed over the
years from the original Sudden Gains study (Tang & DeRubeis, 1999b). In this study, we
reference multiple studies and progression of the criteria, drawing largely from the definition in
the most recent SG study by Tang and DeRubeis (Tang et al., 2007), who were the original
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identifiers of the Sudden Gains phenomenon, and that of Stiles et al. (2003) who adapted the
criteria from its original use with the Beck Depression Inventory to a general distress measure
similar to the OQ-45. The Tang et al. (2007) criteria were as follows:
(a) the gain was ≥ 7 BDI points (absolute magnitude),
(b) the gain represented at least 25% of the pregain session’s BDI score (relative
magnitude), and
(c) the difference between the mean BDI score of the three sessions before the gain (n 2, n - 1, and n) and the three sessions after the gain (n + 1, n + 2, and n + 3) was at
least 2.78 times greater than the pooled standard deviations of these sessions’ BDI
scores (relative to symptom fluctuation) (Tang et al., 2007).
Concerning criterion A, Tang and DeRubeis (1999b) noted that they had tried different
amounts of BDI points, but settled on seven points due to the outcomes obtained at the end of
therapy. Stiles et al. (2003) recognized that 7 points on the BDI was close to its Reliable Change
Index. They then used the Reliable Change Index for their measure for this criterion. Seggar,
Lambert, and Hansen (2002) have found the BDI to have a SD of 6.33 averaged across hundreds
of studies of non-patient samples and 9.99 in clinical samples, with an RCI of 8.46. To keep in
form with past procedures, we used the reliable change index from the OQ-45, which is 14
points (Lambert et al., 2011). Consequently, we will “consider a sudden gain to have occurred
between Session N and Session N + 1 if:
a) The gain was ≥ 14 OQ-45 points
b) The gain represented at least 25% of the pre-gain sessions OQ-45 scores (OQN –
OQN+1 ≥ 0.25 X OQN)
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c) The difference between the mean OQ-45 score of the three sessions before the gain
(OQN-2, OQN-1, and OQN) and the three sessions after the gain (OQn + 1, OQn + 2, and
OQn + 3) was at least 2.78 times greater than the pooled standard deviations of these
sessions’ OQ-45 scores (relative to symptom fluctuation). Keeping in line with Tang
(2007) when applied to session 2, OQN-2 will not be used. Also OQN+3 is not used if
gains occurred on the third to the last session. “Thus, only changes following the first
session and the second-to-last session were excluded. (Tang et al., 2007).”
This last criterion is admittedly arbitrary in nature (Stiles et al., 2003; Tang & DeRubeis,
1999b; Tang et al., 2007), but was used in the present study to be at least partially consistent
with past research and, as such, in this study, the best way to compare the Sudden Gains
phenomena with the other operational definitions.
Rapid Treatment Response (RR). In the software for the OQ-45, cases are labeled as
rapid responders if their reported mental health functioning improves more than expected. This
determination uses the initial OQ-45 score of the participant and compares it to at least 220
individuals from a database of individuals who had the same initial OQ-45 score. Hierarchal
Linear Modeling curves were used to model expected progress (Finch et al., 2001). A score is
considered a RR if the degree of improvement, relative to others with the same initial OQ-45
score, places it within the top 10th percentile. In this study the OQ-45 software (OQ-Analyst)
was used for identification of this criterion.
Haas et al. (2002) took the mean of the first 3 sessions of therapy and then compared the
means to the expectancy curves. Some evidence has shown that using the first three sessions as a
cutoff point when comparing treatment progress to initial OQ-45 scores as RR does, has some
merit (Delgadillo et al., 2014). In this study, those who experienced a RR in the first three
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sessions of therapy were simply labeled Rapid Response (RR) and no attempt was made to
average across sessions as was done by Haas et al. (2002). It should be noted that the cutoff for
inclusion was if the RR was observed by session three, not measurement three. For a more
complete discussion of RR criteria and measuring unexpected dramatic response based on initial
distress scores, the following references can be consulted (Finch et al., 2001; Lambert et al.,
2011; Lambert, Whipple, Smart, Vermeersch, & Nielsen, 2001).
Recovery and reliable change. A client was considered “recovered” if they reliably
improved (i.e., 14 or more points) and entered the ranks of normal functioning as defined by the
Jacobson and Truax (1991) cut-off for normal functioning (i. e., were below 64 at the time of
termination). A client was considered reliably improved if they improved by 14 or more points
but did not end treatment in the non-distressed range (Lambert et al., 2011). Those with OQ-45
scores below a 64 were in the non-distressed range. A client was categorized as experiencing
“no change” if no reliable change occurred, and “deteriorated” if their OQ-45 score at the end of
treatment was reliably worse (i.e., 14 or more points) than at the beginning of treatment.
Results
Groups
Of the 14,689 clients in the archival data base, 12,060 (82.10%) did not meet any of the
criterion for dramatic early change while 2629 (17.90%) experienced some form of unexpected
dramatic treatment response: 1,768 clients (12.04%) experienced a RR, 967 clients (6.58%)
experienced a SG, and 255 clients (1.74%) met PI-50 criteria (Table 1). It should be noted that
the same client could experience one of more of the phenomenon and as such, the percentages do
not add up to an even 100%. It is obvious from Table 1 that wide variation in the number of
cases identified by each methods exists. This makes the likelihood of finding overlap in
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identified cases between cases quite low. As can be seen in Table 1 few clients were classified
as having a dramatic response, particularly when the PI-50 criteria were applied, with the RR
criteria identifying many more clients.

Table 1
Amount of Sample Who Experienced Each Phenomenon
(Overlapping Groups)
Group

n

Percentage of Total Sample

None

12,060

82.00%

PI-50

255

1.74%

SG

967

6.58%

RR

1,768

12.04%

Note. As a client could experience more than one
phenomenon, percentages do not add up to 100%.

Occurrence Rates and Overlap Among Groups
Out of the 2,629 clients who experienced one or more of the phenomena 2295/2629
(89%) only experienced a single phenomenon exclusively. Accordingly, 112/2629 clients
(0.76%) met PI-50 criteria only and not a SG or RR, while 1,469/2629 clients (10.00%)
experienced only a RR and not a PI-50 or SG, and 714/2629 clients (4.86%) experienced only a
SG and not a PI-50 or RR. As a vast majority of those who experienced some form of
unexpected dramatic response did not experience more than one type, this supports the notion
that despite theoretical similarities SG, RR, and PI-50 are markedly different phenomenon.
Overlap that does exist is shown in Table 2 and Table 3 and explained in more detail below.
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Table 2
Overlap Rates Among PI-50, RR, SG (Overlapping Groups)
Base Group

Overlap Group

n

Percentage Overlap of
Base Group

RR

108

42.35%

SG

62

24.31%

PI-50

108

6.11%

SG

218

12.33%

PI-50
RR

62

6.41%

218

22.54%

PI-50
RR
SG

Note. As a client could experience more than one phenomenon,
percentages do not add up to 100%.

Table 3
Overlap Rates Among Independent Phenomena Groups
Group

n

Percentage of
Total Sample

PI-50 Overlap

RR Overlap

SG Overlap

none

12060

82.10%

-

-

-

PI-50 Only

112

0.76%

43.92%

-

-

RR Only

1469

10.00%

-

83.09%

-

SG Only

714

4.86%

-

-

73.84%

PI-50 + RR

81

0.55%

31.76%

4.58%

-

PI-50 + SG

35

0.24%

13.73%

-

3.62%

RR + SG

191

1.30%

-

10.80%

19.75%

PI-50 + RR +
SG

27

0.18%

10.59%

1.53%

2.79%
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Overlap in PI-50. Comparing the 14,689 clients in the database and those who
experienced a PI-50 (n = 255), 35/14,689 clients (0.24%) experienced both a PI-50 and SG,
81/14,689 clients (0.55%) experienced both PI-50 and RR, while 27/14,689 clients (0.18%)
experienced all three phenomena. As such, those who experienced a PI-50 made up the smallest
portion of the overall sample.
When looking more specifically at the 255 clients who met PI-50 criteria a high amount
of overlap was observed: 43.92% experienced only a PI-50 and not a SG or RR, 13.73% both a
PI-50 and a SG, 31.76% both a PI-50 and a RR, and 10.59% experienced all three phenomena
(Table 3 above). As such, 42.35% of those who experienced a PI-50 also experienced a RR
while 24.31% also experienced a SG (Table 2 above). Accordingly, we observe over 50%
overlap between those who experience a PI-50 and either SG or RR. This suggests that while PI50 may be the most restrictive criteria when related to the overall sample population, many
clients who experience a PI-50 likely experience another phenomenon.
Overlap in RR. Comparing the 14,689 clients in the database and those who experienced
a RR (n = 1768), 81/14,689 (0.55%) experienced both a RR and PI-50, 191/14,689 clients
(1.30%) experienced both a RR and SG, while 27/14,689 clients (0.18%) experienced all three
phenomena. As such, those who experienced a RR made up the larger portion than either SG or
PI-50 but still minority portion of the overall sample.
When looking more specifically at the 1768 clients who experienced a RR, a relatively
low amount of overlap with other phenomena was observed: 83.09% only experienced a RR and
not a PI-50 or SG, 4.58% experienced both a RR and PI-50, 10.80% experienced both a RR and
SG while 1.53% experienced all three phenomena (Table 3 above). As such, 6.11% of those
who experienced a RR also experienced a PI-50 while 12.33% also experienced a SG (Table 2
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above). Accordingly, a vast majority of those who experienced a RR did not experience an
overlapping SG or PI-50 phenomenon. Despite having more similarities in methodology with
the PI-50 phenomenon in terms of dosage, the highest amount of overlap for RR was with those
who experienced a SG also. However, the low mount of clients who experienced both a RR and
another phenomenon (16.91%) suggests that the RR phenomenon differs largely from others
despite the theoretical and methodological similarities mentioned previously.
Overlap in SG. Comparing the 14,689 clients in the database and those who
experienced a SG (n = 967), 35/14,689 (0.24%) experienced both a SG and PI-50, 191/14,689
(1.30%) experienced both a SG and RR, while 27/14,689 (0.18%) experienced all three
phenomena. As such, those who experienced a RR made up the larger portion than either SG or
PI-50 but still minority portion of the overall sample.
When looking more specifically at the 967 clients who experienced a SG a relatively low
amount of overlap with other phenomena was observed: 73.84% only experienced a SG and not
a PI-50 or RR, 3.62% experienced a SG and PI-50, 19.75% experienced a SG and RR, while
2.79% experienced all three phenomena (Table 3 above). As such, 6.41% of those who
experienced a SG also experienced a PI-50 while 22.54% also experienced a RR (Table 2
above). As a vast majority of those who experienced a SG did not experiencing an overlapping
RR or PI-50 phenomenon this suggest vast differences between SG and RR or PI-50 despite the
theoretical and methodological similarities mentioned previously.
Comparing Descriptives
Each phenomenon was compared on different unique descriptive characteristics in an
effort to analyze for differences present in the populations who met criteria for each phenomenon
(see Table 4).
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Table 4
Descriptive Statistics for Independent Groups
Total
Treatment
Sessions

Group

Number
of
Measurements

Total
Weeks in
Treatment

Initial
OQ-45
Scores

Ending
Total
OQ-45 Change on
Scores
OQ-45

M

12.71

8.42

54.50

83.49

73.66

9.82

Md

6.00

4.00

14.43

81.00

73.00

6.00

2

1

68

69

0.00

Mode
None
(n = 12060) SD

20.18

11.79

84.34

14.62

21.17

19.06

Min.

1.00

1.00

0.00

64.00

0.00

-102.00

Max.

670.00

233.00

810.14

171.00

176.00

119.00

M

10.43

7.22

53.72

94.77

48.47

46.29

Md

5.00

4.00

12.71

92.00

44.50

49.50

3

3

71

51

PI-50
Only
(n = 112)

RR Only
(n = 1469)

SG Only
(n = 714)

Mode

0.00

2

106

SD

19.38

9.95

82.06

17.61

23.78

23.34

Min.

3.00

2.00

0.86

64.00

3.00

-35.00

Max.

173.00

83.00

415.43

135.00

114.00

94.00

M

10.63

8.43

46.25

89.51

65.48

24.03

Md

6.00

5.00

14.71

88.00

64.00

24.00

3

3

73

74

21

Mode

1

SD

16.79

10.51

63.79

15.98

21.03

18.64

Min.

2.00

2.00

0.29

64.00

5.00

-55.00

Max.

280.00

139.00

383.14

148.00

144.00

95.00

M

26.47

20.69

112.60

83.44

55.09

28.36

Md

16.00

14.00

74.29

81.00

53.50

28.00

80

46

39

Mode

7

7

7

SD

30.86

20.73

112.35

14.12

23.35

24.21

Min.

4.00

4.00

1.71

64.00

0.00

-62.00

Max.

417.00

216.00

663.71

136.00

141.00

104.00
(continued)
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Table 4. Descriptive Statistics for Independent Groups
Total
Treatment
Sessions

Group

PI-50 +
RR
(n = 81)

PI-50 +
SG
(n = 35)

RR +
SG
(n =
191)

PI-50 +
RR +
SG
(n = 27)

Number
of
Measurements

Total
Weeks in
Treatment

Initial
OQ-45
Scores

Ending
Total
OQ-45 Change on
Scores
OQ-45

M

11.44

8.81

63.62

99.98

56.19

43.79

Md

6.00

5.00

19.14

100.00

52.00

50.00

3

3

86

30

45

Mode

4

SD

15.62

10.29

83.37

17.20

28.48

25.66

Min.

3.00

2.00

1.14

67.00

6.00

-26.00

Max.

97.00

57.00

386.00

156.00

160.00

85.00

M

12.00

9.99

72.84

105.80

53.17

52.63

Md

8.00

7.00

25.86

105.00

50.00

59.00

5

4

95

26

66

Mode

6.57

SD

10.23

7.57

101.13

14.10

28.07

26.04

Min.

4.00

4.00

2.86

77.00

8.00

7.00

Max.

49.00

32.00

516.71

140.00

121.00

107.00

M

19.27

16.28

71.57

87.21

53.80

33.41

Md

10.00

9.00

35.86

86.00

49.00

34.00

72

43

32

Mode

4

4

5

SD

27.68

20.80

88.62

14.98

23.83

21.81

Min.

4.00

4.00

2.71

64.00

3.00

-48.00

Max.

211.00

173.00

396.43

143.00

150.00

104.00

M

9.63

8.70

56.77

103.96

46.67

57.30

Md

6.00

6.00

17.86

101.00

45.00

60.00

4

4

81

41

61

Mode

3

SD

11.78

8.63

74.63

16.36

16.03

17.34

Min.

4.00

4.00

3.00

81.00

21.00

22.00

Max.

59.00

39.00

241.14

144.00

88.00

106.00

Note. When multiple modes existed, the smallest value was used.
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Beginning of treatment. In order to be analyzed for differences in distress levels at the
beginning of treatment, clients were divided into non-overlapping groups based on the
phenomena they had experienced. These included clients who met criteria for only one of the
three phenomena (SG, RR, PI-50), all paired combinations (i.e., SG and PI-50, SG and RR, etc),
those who met all three criteria, and those who met criteria for none of the groups. An ANOVA
(F(7, 14681) = 71.02, p < .000) showed significant differences in distress at the beginning of
treatment between the non-overlapping groups tested. Those who met criteria for PI-50 and SG
had the highest initial severity (M =105.80), while those who met criteria for SG only had the
lowest (M = 83.44). Using Tukey’s B Post-hoc analysis, four populations were seen among the
eight possible combinations, as seen in Table 5, which displays each group’s mean distress
scores at the beginning of treatment. Each of the independent groups of clients in the same
population in Table 5 did not differ significantly from one another on mean OQ-45 scores at the
start of treatment but did differ significantly from the other populations. As such, we see all
groups that experienced a PI-50 had significantly higher beginning of treatment distress scores
than the groups that did not experience a PI-50 but that there was a large amount of overlap seen
throughout the groups.
In order to better understand the differences in beginning of treatment distress levels, a
regression was run using initial severity as the dependent variable and entering whether or not a
client met criteria for each phenomenon (i.e., SG, RR, or PI-50) into the model as a dichotomous
variable. The regression showed that meeting criteria for experiencing each of the phenomena
predicted beginning of treatment distress levels significantly. Examining the unstandardized beta
coefficient reveals the nature of the effect of experiencing each of the phenomena. When
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examining those who had experienced none of the phenomena, the regression model indicates
that the mean initial severity score, as measured by the OQ-45, was approximately 83.50. Those
who had experienced SG had a mean score that was .04 points lower than the overall group mean
and was not statistically significant (t(14681) = -0.84, p = .93); those who had experienced a PI50 had a mean score 13.02 points higher (t(14681) = 13.77, p < .05); and those who met criteria
for RR had a mean score 5.67 points higher (t(14681) = 14.97, p < .05). This indicates that the
PI-50 and RR methods tended to identify clients who were more distressed at treatment onset
while the SG method identifies clients who are typical in disturbance of all those who entered
therapy.
Table 5
Tukey Comparison for Beginning of Treatment Distress
Different Groups

n

Mean OQ-45 Scores
Population
1

Population
2

Population
3

Population
4

SG only

714

83.44

None

12060

83.49

RR + SG

191

87.21

RR only

1469

89.51

PI-50 only

112

PI-50 + RR

81

PI-50 + RR + SG

27

103.96

PI-50 + SG

35

105.80

89.51
94.77

94.77
99.98

99.98

Note. Group means did not differ from one another in same population but did
differ from other population. See text for more details.
These unstandardized coefficients can be understood additively. For example, those who
had experienced both a RR and PI-50 would have a predicted mean on the OQ-45 at the
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beginning of treatment approximately 18.69 points higher than the overall mean score of 83.50.
Additionally, those who met criteria for both SG and RR would have a predicted initial severity
approximately 5.63 points higher than the overall mean score. These findings are congruent with
the Tukey’s B reported earlier, where those who had experienced only SG showed significantly
lower initial severity than the RR and PI-50 groups and those who had experienced PI-50
showed significantly higher initial distress levels, and that those who experienced both SG and
RR along with those who experienced just a SG were not significantly different from those who
experienced none of the phenomena. As such, it is likely that RR and PI-50 criteria are
somewhat closely related to elevated initial OQ-45 scores while SG is not dependent on initial
scores.
End of treatment. Comparing non-overlapping groups categorized by the phenomena
they had experienced based on their end of treatment OQ-45 scores, an ANOVA (F(7, 14681) =
146.21, p < .000) showed significant differences in psychological distress at the end of treatment.
Those who met criteria for none of the phenomena had the highest end severity (M = 73.66.),
while those who met criteria for all three of the phenomena (M = 46.67) had the lowest end
severity. Using Tukey’s B Post-hoc analysis, two populations were observed were observed
among the eight possible combinations, as seen in Table 6. Accordingly, clients in the
independent groups that make up population one are alike in their end of treatment distress levels
while all clients in the independent groups that make up population two were alike but each
population differed significantly from one another in end of treatment distress scores. As such,
clients who experienced none of the phenomena and clients who experienced just a RR made a
single population (population 2 on the table below) and did not differ significantly from one
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another in end of treatment distress but had significantly different end of treatment distress
scores than the other population (population one on the table below).
With the exception of those who experienced only a RR and not a SG or PI-50, we see that those
who experienced any combination of phenomena did not differ from one another in end of
treatment distress scores but as a population together displayed significantly lower end of
treatment distress scores than those who experience none of the phenomena.

Table 6
Tukey Comparison for End of Treatment Distress
Different Groups

n

Mean OQ-45 scores
Population 1

Population 2

PI-50 + RR + SG

27

46.67

PI-50 only

112

48.47

PI-50 + SG

35

53.17

RR + SG

191

53.80

SG only

714

55.09

PI-50 + RR

81

56.19

RR only

1469

65.48

None

12060

73.66

When analyzing end of treatment scores on an outcome measure the need arises to
control for beginning treatment scores. An ANOVA (F(8, 14680) = 689.09, p <. 000) was run,
controlling for beginning treatment scores on the OQ-45, and also showed significant differences
in psychological distress at the end of treatment.
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A regression showed that meeting criteria for experiencing each of the phenomena
predicted end of treatment distress levels significantly. The regression indicated a mean ending
severity score for all subjects on the OQ-45 of approximately 73.49. Those who had experienced
SG had a mean score that was 16.40 points lower than the mean score for the entire population
(t(14685) = -22.84, p < .05); those who had experienced a PI-50 had a mean score 15.14 points
lower (t(14685) = -11.06, p < .05); and those who met criteria for RR had a mean score 7.03
points lower (t(14685) = -12.80, p < .05). These findings are somewhat congruent with the
Tukey’s B reported earlier, where only two groups, those who had experienced none of the
phenomena and those who experienced only a RR and not a SG or PI-50, showed significantly
higher ending severity than the group that experienced two or three of the phenomena. This is
more evidence that in the area of end of treatment distress SG and PI-50, are similar to one
another while RR seems to be somewhat closer to the population mean and perhaps in some
cases not significantly different from clients who experienced no other phenomena.
A regression controlling for beginning OQ-45 scores showed that meeting criteria for
experiencing each of the phenomena predicted end of treatment distress levels significantly. The
regression indicated a mean ending severity score on the OQ-45 of approximately 60.19 after
adjusting for beginning OQ-45 scores. Those who had experienced PI-50 had a mean score that
was 24.02 points lower than the mean score for the entire population after adjusting for initial
distress scores (t(14684) = -19.76, p < .05); those who had experienced a SG had a mean score
16.37 points lower (t(14684) = -25.85, p < .05); and those who met criteria for RR had a mean
score 10.90 points lower (t(14684) = -22.34, p < .05). When correcting for beginning OQ-45
scores the distance from the overall mean end of treatment distress score increased for those who
experienced any of the three phenomena.
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Total change. To compare non-overlapping groups categorized by the phenomena they
had experienced and based on their total change in OQ-45 scores, an ANOVA (F(7, 14681) =
324.15, p < .000) showed significant differences in distress at the end of treatment. Those who
met criteria for none of the phenomena had the lowest amount of overall change during treatment
(M = 9.82.), while those who met criteria for all three phenomena (M = 57.30) had the highest
amount of change in distress levels over the course of treatment. Using Tukey’s B Post-hoc
analysis, six populations were seen among the eight possible combinations, as seen in Table 7.
Those groups in each population do not differ significantly from one another but do differ from
groups in other populations in mean total change over the course of treatment. These scores
indicate a high amount of difference and little consensus among each of the independent groups
in the amount of total change at the end of treatment.
Table 7
Tukey Comparison Total Change

Mean Q-45 Scores by Population
Different Groups

n

Population
1

None

12060

9.82

RR only

1469

24.03

SG only

714

28.36

RR + SG

191

PI-50 + RR

81

43.79

PI-50 only

112

46.29

PI-50 + SG

35

PI-50 + RR + SG

27

Population
2

Population
3

Population
4

Population
5

Population
6

28.36
33.41

46.29
52.63

52.63
57.30
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However, it is of note that total change scores for those who experience none of the
phenomenon (M = 9.82) are almost 2.5 times less total change on the OQ-45 than the next
closest mean total change score, RR only (M = 24.03), indicating that experiencing any of these
phenomena is associated with dramatically higher amounts of total change over the course of
treatment (Figure 1). Also, those groups that include PI-50 seem to show no overlap with any
group that does not include a PI-50, indicating significantly higher amounts of total change
among those who experience a PI-50.

70.00
60.00
50.00
40.00
30.00
20.00
10.00
0.00
None

RR only

SG only

RR + SG

PI-50 Only PI-50 + SG PI-50 + SG +
RR

Figure 1. Total Change in Distress, over treatment by independent group

To determine whether or not total change over the course of treatment was still predicted
by experiencing a SG, RR, or PI-50 when controlling for beginning distress levels an ANOVA
(F(8, 14680) = 415.50, p < .001) was run controlling for initial scores on the OQ-45which also
showed significant differences in total change of psychological distress as predicted by
experiencing these phenomena.
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A regression showed that meeting criteria for experiencing each of the phenomena
significantly predicted the total amount of change in mental health functioning over the course of
treatment. The regression indicated that the mean total change over the course of treatment for
all subjects was approximately 10.01 points on the OQ-45. Those who had experienced a RR
had a mean score that was 12.70 more points total change than the population mean (t(14684) =
25.46, p < .05); those who had experienced a SG had a mean score 16.36 points more (t(14684)
= 25.46, p < .05); and those who met criteria for PI-50 had a mean score 28.16 points more
(t(14684) = 22.63, p < .05). These findings are congruent with the Tukey’s B reported earlier,
where those who had experienced none of the phenomena showed significantly lower total
change over the course of treatment than those that met criteria for any of the phenomena. It also
coincided with the finding that experiencing a PI-50 in any combination with other phenomena is
correlated with those who experienced the most change throughout treatment but that different
combinations of experiencing each phenomenon seemed somewhat independent of one another.
A regression controlling for beginning OQ-45 scores showed that meeting criteria for
experiencing each of the phenomena predicted total change in distress levels significantly. The
regression indicated that the mean total change score of approximately 3.81 for all subjects after
adjusting for beginning distress levels. Those who had experienced PI-50 had a mean total
change score that was 24.02 points higher than the population mean (t(14684) = 19.76, p < .05);
those who had experienced a SG had a mean score 16.37 points higher (t(14684) = -25.85, p <
.05); and those who met criteria for RR had a mean score 10.90 points higher (t(14684) = -22.34,
p < .05).
Number of sessions. Comparing non-overlapping groups categorized by the phenomena
they had experienced based on the amount of sessions they attended, an ANOVA (F(7, 14681) =
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49.53, p < .000) showed significant differences in total amount of sessions attended in treatment.
Those who experienced all three phenomena attended the lowest amount of sessions during
treatment (M = 9.63.), while those who experience only a SG met for the most sessions over the
course of treatment (M = 26.47). Using Tukey’s B Post-hoc analysis, three populations were
seen among the eight possible combinations, as seen in Table 8. Those groups in each
population did not differ significantly from other groups in the same population in total sessions
attended but did significantly differ from groups in the other populations. There is a high
amount of overlap among these independent populations as many groups occupy two
populations. This may indicate a significant variance in total number of sessions across the
population but a lack of separation between each independent group.

Table 8
Tukey Comparison for Total Number of Sessions Attended
Throughout Treatment

Different Groups

n

Mean Sessions attended
Population
1

Population
2

PI-50 + RR + SG

27

9.63

PI-50 only

112

10.43

10.43

RR only

1469

10.63

10.63

PI-50 + RR

81

11.44

11.44

PI-50 + SG

35

12.00

12.00

None

12060

12.71

12.71

RR + SG

191

SG only

714

19.27

Population
3

19.27
26.47
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A regression showed that meeting criteria for experiencing each of the phenomena
significantly predicted the total amount of sessions attended over the course of treatment. This
regression indicated that the mean total sessions attended for all subject was approximately
12.79. Those who had experienced SG had attended an average of 12.06 more sessions than the
population mean (t(14685) = 17.47, p < .05); those who had experienced a PI-50 had attended
3.80 fewer sessions (t(14685) = -2.89, p < .05); and those who met criteria for RR had attended
2.46 fewer sessions (t(14685) = -4.66, p < .05). These findings are congruent with the Tukey’s B
post hoc analysis reported earlier, where those who had experienced a SG attended significantly
more sessions over the course of treatment, while, overall, any combination of experienced
phenomena were closely bunched together in number of sessions attended.
Weeks in treatment. Comparing non-overlapping groups based on the phenomena they
had experienced, an ANOVA (F(7, 14681) = 50.51, p < .000) showed significant differences in
weeks in treatment. Those who met criteria for only a RR had the lowest amount of weeks in
treatment (M = 46.25), while those who met criteria for only a SG had the highest amount of
weeks in treatment (M = 112.60). Using Tukey’s B Post-hoc analysis, two populations were
seen among the eight possible combinations, as seen in Table 9. Those groups in the same
population did not differ significantly on total weeks in treatment from other groups in the same
population but did differ significantly from those groups in the other populations. These
populations indicate little discernible significant difference is seen between those who
experience any of the phenomena in total number of weeks in treatment with the exception of
those who experienced a SG and no other phenomena. This group spent significantly more
weeks in therapy than all other independent groups studied.
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Table 9
Tukey Comparison for Total Weeks of Treatment
Different Groups

n

RR only
PI-50 only
None
PI-50 + RR + SG
PI-50 + RR
RR + SG
PI-50 + SG
SG only

1469
112
12060
27
81
191
35
714

Mean number weeks in
treatment
Population Population
1
2
46.25
53.72
54.50
56.77
63.62
71.57
72.84
112.60

A regression showed that meeting criteria for experiencing each of the phenomena
predicted differences in the number of weeks between the first and last sessions. The regression
model indicated the mean weeks in treatment for all subjects was approximately 54.95. Those
who had experienced PI-50 had approximately of 2.46 fewer weeks in treatment more than the
population mean (t(14685) = -0.46, p = 0.65) and was not significantly different from the
constant. Clients who had experienced a SG had on average 49.18 more weeks in treatment
(t(14685) = 17.41, p < .05); and those who met criteria for RR had on average 10.90 fewer weeks
in treatment (t(14685) = -5.05, p < .05). These findings are somewhat congruent with the
Tukey’s B reported earlier, where those who had experienced a SG had significantly higher
amounts of total weeks in treatment, while those who experienced a SG or RR did not differ
from those who experienced none of the phenomena in weeks in treatment. Accordingly, we
would expect those who experienced a SG and no other phenomenon to be more likely to be in
treatment longer than the overall sample population, those who experienced a RR or PI-50, or
even those who experienced a SG in combination with other phenomena.
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Recovery. Of the 14,689 clients in this study, 4,278/14,689 (29.1%) recovered by the
end of treatment, while an additional 2,013/14,689 (13.7%) showed reliable improvement but did
not fit criteria for recovery, 7,499/14,689 (51.1%) experienced no significant change, and
899/14,689 (6.1%) had deteriorated. Individual rates of recovery, reliable change, no change,
and deterioration are shown in table 10. Recovery rates for those in all eight possible
combinations of the phenomena (no criteria, only PI-50, only SG, only RR, PI-50 + SG, PI-50 +
RR, SG + RR, PI-50 + SG + RR) were significantly different (χ2 = 1871.96, p < .001). In seven
of the eight independent groups (excluding those who experienced only a RR and no other
phenomena), a majority of clients recovered by the end of treatment, all 8 independent groups
had at least 70% reliable improvement or recovery, and none had over a 5% deterioration rate
(Table 10).
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Table 10
Recovery Rates Among RR, SG, PI-50 (Non-overlapping Groups)

Recovered

Reliable
Improvement

No Change

Deteriorated

RR +
SG

PI-50 +
RR +
SG

None

Total

24

131

24

2857

4278

67.9%

68.6%

68.6%

88.9%

23.7%

29.1%

92

12

6

31

3

1383

2013

31.7%

12.9%

14.8%

17.1%

16.2%

11.1%

11.5%

13.7%

9

283

162

11

5

24

0

7005

7499

% recovered

8.0%

19.3%

22.7%

13.6%

14.3%

12.6%

0.0%

58.1%

51.1%

n

2

45

29

3

0

5

0

815

899

% recovered

1.8%

3.1%

4.1%

3.7%

0.0%

2.6%

0.0%

6.8%

6.1%

PI-50
only

RR
only

SG
only

PI-50 + PI-50 +
RR
SG

n

80

676

431

55

% recovered

71.4%

46.0%

60.4%

n

21

465

% recovered

18.8%

n

39
90.0%
80.0%
70.0%
60.0%
50.0%
40.0%
30.0%
20.0%
10.0%
0.0%
PI-50 only

RR only
Recovered

SG only

PI-50 + RR

PI-50 + SG

Significant Improvement

RR + SG

No Change

PI-50 + RR +
SG

None

Deteriorated

Figure 2. Percentage of Those who experienced each phenomena that recover, significantly
improve, or deteriorate

Table 11
Recovery Rates Among PI-50, RR, SG (Overlapping Groups)
PI-50
Recovered
Reliable
Improvement
No Change
Deteriorated

n
% recovered
n
% recovered
n
% recovered
n
% recovered

RR

SG

None

2857
183
886
610
71.76% 50.11% 63.08% 23.69%
1383
42
511
132
11.47%
16.47% 28.90% 13.65%
7005
25
318
191
9.80% 17.99% 19.75% 58.08%
815
5
53
34
1.96%
3.0%
3.52% 6.76%

Those clients who experienced any of the phenomena accounted for a significant
percentage of the overall group of those who were classified as “recovered” by the end of
treatment (n = 4278) (Figure 2). Those who experienced a RR accounted for 20.71%, PI-50 for
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4.28%, and SG for 14.26% of all clients in the sample classified as recovered at the end of
treatment.
Testing RR that Occurred All Throughout Treatment
A secondary analysis was completed looking at clients who experienced a RR any time
throughout their treatment instead of just the first three sessions. In this sample 14,694 clients
were analyzed from the same database as the primary analysis and 3,549/14,694 (24.15%)
experienced a RR at any time throughout treatment. Comparing all clients in the database and
those who experienced a RR, 610 clients (17.18%) experienced both a RR and SG. Conversely
these 610 clients who experienced both a SG and a RR throughout treatment accounted for
almost half (48.28%) of all who experienced a SG in the sample. These overlap rates between
those who experienced a SG who also experienced a RR were much higher than when examining
RR that occurred in just the first the first three sessions. However, even at these higher rates of
overlap, more than 50% of those who experienced a SG still did not experience a RR. This
indicates that significant differences still exist between phenomena, even when the criteria for
RR is expanded in timeframe.
A comparison in recovery rates was made using RR criteria that occurred any time in
treatment rather than just the first three sessions. Of those who experienced a RR any time
during treatment 1860 (52.41%) recovered. In addition, those who experienced a RR any time
throughout treatment and were classified as “recovered” accounted for 43.47% of all the clients
in the entire sample who were classified as “recovered” by the end of treatment. An examination
of clients who experienced both a SG and RR and met criteria to be “recovered” at the end of
treatment yielded 422 clients accounting for 22.69% of all those who experienced a RR any time
throughout treatment and met criteria for recovery. Conversely, these 422 clients accounted for
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52.95% of all those who experienced a SG and were classified as “recovered” at the end of
treatment, a portion of the population much higher than when examining RR in only the first
three sessions. This is further evidence that more similarities lie between RR and SG when RR
criteria is expanded to any time throughout treatment but that there are still significant
differences in those who experience each of the phenomena and are classified as “recovered” at
the end of treatment. Further, when comparing RR that occur any time in treatment the
percentage of clients who experience a RR that recover is larger. This somewhat challenges
notion that “early” is necessary criteria for best outcomes with the RR method.
Discussion
The purpose of this study was to compare three methods for operationalizing unexpected
dramatic treatment response and analyze the degree of overlap between methods. Similarities
and differences between methods with regards to base rates of occurrence will first be discussed,
followed by an examination of differences in outcomes of identified clients. Interpretations and
implications of the results will be explored in the context of past research and clinical practice.
Limitations of the study will then be examined while differences in particular of methodology
between SG, PI-50, and RR will be highlighted followed by a conclusion section which attempts
to summarize the study and suggest future research directions.
Similarities Between Phenomena
Phenomena are predictive. Despite differences between method base rates, clients who
experienced any of the three phenomena had better treatment outcomes than those clients who
did not meet criteria. This is in line with research literature on the topic. In these past studies,
better outcomes were shown at the end of treatment and even up to two years after the end of
treatment across all three phenomena. The primary RR study referenced (Haas et al., 2002)
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demonstrated fewer psychological symptoms at termination of treatment and follow-up with a
maintenance of the unexpected dramatic response seen during treatment. The reference PI-50
study (Renaud et al., 1998) demonstrated similar predictions of better outcomes at the end of
treatment, one year, and two year follow-up periods. Lastly, a meta-analysis of 16 SG studies
(Aderka et al., 2012) demonstrated moderate effects on outcome measured at post treatment and
follow-up in CBT and non-CBT studies that used RCT and ITT analyses, specific symptom
measures and general measures of distress, and across a variety of different diagnoses and
treatment settings.
It might be said that “all roads lead to Rome” in the case of treatment recovery
concerning the three methodologies used to identify unexpected dramatic treatment response. In
this study, meeting criteria for a PI-50, RR, or SG gain was tied to higher recovery and reliable
change at the end of treatment. Those clients not identified by any of the three methods had a
recovery rate of 24%, with an additional 12% reliably improving but not recovering. In contrast,
73 to 90% improved or recovered if identified by any of the methods. This is evidence that
despite differences in methodology base rate of identification, SG, PI-50, and RR may all be
promising methodologies for use as predictors of recovery or improvement.
Interestingly, in our secondary analysis we observed that a similar rate of recovery was
seen when comparing those who experienced a RR in the first three sessions and those who
experienced a RR any time throughout therapy (50% vs 52%). However, differences were seen
in the number of the total sample of clients classified as “recovered” at the end of treatment
captured by the RR method. In the more restricted first three sessions method, 20.71% of those
who were classified as “recovered” at the end of treatment experienced a RR.
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In contrast, when expanded to allow RR any time throughout therapy, 43.47% of those
who were classified as “recovered” at the end of treatment had experienced a RR sometime
during treatment. In addition, more overlap with those who were classified as “recovered” and
had experienced a SG was seen with this expanded criterion. When in the secondary analysis
criteria was expanded to include RR any time in treatment, of those who experienced a SG just
over half of the clients (52.95%) also experienced a RR and were classified as “recovered” at the
end of treatment. This may be an indication that more overlap with SG exists between RR that
occur throughout treatment than in those that occur in the first three sessions of treatment.
Nevertheless, the overlap between SG and RR across all sessions is not total and a vast majority
of those who experienced a RR any time throughout treatment did not experience a SG
suggesting that even in this condition RR criteria is the least restrictive in identifying unexpected
dramatic treatment response and that significant differences between SG and RR exist.
Overlap between PI-50 and other phenomena. This analysis looked at clients who
experienced more than one phenomena to identify overlapping cases. These overlapping cases
would demonstrate similarities between methodologies used to capture unexpected dramatic
change in psychotherapy. While the overlap overall is low between those who experienced RR,
PI-50, and SG respectively there seems to be some overlap within groups that is of interest. In
those who experienced a PI-50, over 40% also experienced a RR (42.35%) and almost a quarter
also experienced a SG (24.31%). Some of this overlap may be explained by PI-50 being
experienced by a considerably smaller amount of clients when compared to SG and RR and as
such, taking a narrower view of unexpected dramatic treatment response. Therefore, this
narrower sample of those who experienced a PI-50 may somewhat overlap with RR’s more
liberal identification. In addition, RR and PI-50 share a common criterion of needing to see
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unexpected and dramatic response by session three of treatment. Due to this shared
methodology criteria and the possibility PI-50 may be examining a narrower range of clients, the
over 40% overlap may be expected.
Differences Between Phenomena
Occurrence rate. In this study, vastly different numbers of clients were identified based
on operational criteria for each method. Applying PI-50, RR, and SG methodology to the same
database, a relatively larger sample of individuals met criteria for RR (n = 1768) than other
methods: SG (n = 967) PI-50 (n = 255). It should be noted that the percentage of the population
identified is much lower in this study than past RR and SG studies. For example, the metaanalysis by (Aderka et al., 2012) with past SG studies have shown the SG phenomenon present
in anywhere from under 15% (Hofmann et al., 2006) to over 52% (Doane, Feeny, & Zoellner,
2010) of the samples examined with a large variance from study to study. Stiles et al. (2003)
looked at a community sample similar to that of this study, that utilized multiple diagnoses and
treatment modalities like this study, and used a similar outcome measure to the OQ-45, the
CORE-SF. They identified SG in 17.8% of their sample. This is still over twice the percentage
of the 967 (6.58%) clients who identified as experiencing a SG in this study. Further, in Haas et
al. (2002) exactly 1/3 of the sample experienced a RR, which is significantly higher than the just
over 12% identified in this study. When in our secondary analysis, we examine RR across all
sessions we do get a larger sample (24.15%) that experience a RR that is somewhat closer to the
1/3 seen in Haas et al. (2002).
While the reasons for these dissimilar occurrence rates are unknown they do offer some
points of comparison between unexpected dramatic treatment response methodologies. These
dissimilar occurrence rates suggest that that RR was the most liberal indicator of unexpected
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dramatic response even though it was based on just the first three sessions of care, while PI-50
was by far the most conservative with SG in the middle.
In particular, PI-50 only being experienced by less than 2% of the sample, may pose
limited usefulness as a predictive measure or clinician feedback tool due to its unlikeliness of
observation. This is likely correlated with the second requirement that 25% of the entire range of
the instrument take place to experience a PI-50. In the OQ-45 this amounts to 45 points of
change. Further, the clinical cutoff score from instrument to instrument falls at a different
proportion of the scale. As such, our limited occurrence rate for the PI-50 may be due to this
discrepancy and as such as Hiller et al. (2012) suggests occurrence rate of PI-50 should likely not
be compared across measures.
One possible future area of exploration that may enhance the utility of PI-50 as a method
of identification of unexpected dramatic treatment response early in treatment are the exploration
of the changing of the second criteria requiring 25% of the entire instrument. This criteria may
be change to be 25% of the entire clinical range or even different percentages examining if more
clients are identified while still maintaining its high correlation with treatment outcomes.
Overlap rates. A main focus of this study was to examine the similarity between SG,
PI-50, and RR by examining how many of the same clients would meet criteria for experiencing
one or more of the presumably overlapping phenomena when applied to the same sample and
using the same outcome measure. If a high percentage of the same clients met criteria for two or
more of the phenomena, it would support uniformity and similarity in the practical application of
these concepts, whereas a low percentage of overlap suggests the opposite.
It was surprising how few of those who experienced each of the unexpected dramatic
response definitions overlapped with others. A large majority of those who experienced a RR
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(83.09%) did not meet criteria for a SG or PI-50 while a large portion of those who experienced
a SG (73.84%) did not experience a RR or PI-50 phenomena. When identifying clients who
experienced all three of the phenomena, a tiny number of clients qualified (n = 27). This only
accounts for 0.18% of the total sample and 1.03% of those who met criteria for having
experienced one or more of the PI-50, RR, and SG phenomena. If PI-50, SG, and RR were all
truly similar in identifying unexpected dramatic treatment response, we would likely observe
many more clients who experienced all three phenomena. Accordingly, the lack of overlap
suggests that RR, SG, and PI-50 are accounting for vastly different phenomenon despite their
similar goal to attempt to identify unexpected dramatic treatment response.
Of particular note, a vast majority of those who experience a SG or RR did not
experience any other phenomena illustrating a particularly large dissimilarity between these two
methodologies. This lack of overlap between SG and RR is likely the most important finding of
this study. Careful effort was taken to use the criteria on the same database of individuals with
the same measure and similar, naturalistic treatment setting to find clients who experienced
multiple phenomena rather than merely to compare incident rates across studies yet differences
persist and relatively little overlap was seen among clients. This is evidence in practical
application methodology demonstrating differences rather than only comparing similar
theoretical underpinnings of unexpected dramatic treatment response.
Differences in criteria between methods may account for lack of overlap between the
clients who experienced each phenomena. For example, both PI-50 and RR require unexpected
dramatic change to be observed in the first three sessions of treatment. In contrast, SG
methodology has a higher requirement for sustaining gains since they have to occur for at least
two measurements post gain when compared to the two measurements pre gain. This pre-gain
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requirement alone in the methodology suggests that it may be difficult for many who experience
a SG to meet either the PI-50 or RR early treatment requirement.
The secondary analysis that examined RR occurring throughout the entire treatment and
compared them with the RR that occurred in the first 3 sessions supports these observed
differences. In the analysis using the less restrictive RR criteria that occurred any time in
treatment, it was found that over 48% of those who experienced a SG also experienced a RR.
While this is a higher amount of overlap with SG, a majority of those who experienced a SG still
did not experience a RR even with these more loose criteria, while the expanded RR criteria also
identified many more respondents that did not experience a SG than those that did. As such,
even with the expanded criteria allowing a RR throughout treatment, SG and RR still show
significant differences in the clients identified that experience them.
These findings indicate, therefore, that despite a lack of total synchronicity between all
three phenomena, there is some overlap between two phenomena, such as PI-50 and RR that may
be due to PI-50 methodology’s more conservative approach. However, while there are definite
similarities in outcome and in the way each of the phenomena is theoretically conceptualized as
capturing unexpected dramatic treatment response, the lack of high overlap in clients identified
using SG, RR, and PI-50 methodology suggests that each phenomena is significantly different
from one another. Therefore, caution may be warranted when using SG, RR, and PI-50 as
interchangeable operationalizations for those who experience unexpected dramatic treatment
response.
Comparing Differences in Descriptive Statistics
Without exception, experiencing a RR, SG, or PI-50 predicted differences on every
descriptive statistic examined and compared in our analysis. These differences were seen in
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beginning of treatment distress level, end of treatment distress level, and total change of distress
levels. As we have observed that there is at least some undoubtable differences between each of
the three phenomena, some helpful illuminations might be taken from examining available
descriptive information concerning the clients who experienced each of the phenomena.
Beginning of treatment distress. Significant differences were seen in beginning of
treatment distress levels between phenomena. These differences were not only significant but
varied widely. Interestingly, when looking at independent groups, any combination of those who
experienced a SG or RR without a PI-50 were grouped in the same population of starting distress
levels with those who experienced none of the three phenomena. Also, the regression model
suggested that those who experienced a SG did not differ from the population mean in beginning
OQ-45 distress. In contrast, experiencing a PI-50 had an additive effect over the overall
population mean of over 2 times the OQ-45 points than that of RR in beginning distress levels.
This data suggests that those who experienced a SG may differ little from those who experience
none of the phenomena on beginning distress scores while some who experience a RR and most
of those who experience a PI-50 start with significantly higher distress scores.
Some of these differences may even be due to the operational definition in the concepts
behind each phenomenon. For example, RR is largely concerned with gains that exceed
expected change with an emphasis on beginning distress scores (Haas et al., 2002). In contrast,
SG creators defined their operational definition of the phenomenon as “sudden, substantial, and
stable improvements that occur in one between-session interval” (Busch et al., 2006; Tang &
DeRubeis, 1999b). Thus it is possible that clients who experienced a RR had significantly higher
beginning of treatment OQ-45 scores in the regression model due in part to conceptual focus on
beginning OQ-45 scores in defining its methodology. Accordingly, beginning of treatment
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distress levels are a descriptive characteristic that may illuminate drastic differences between
these supposedly similar phenomena despite their conceptual similarities.
The fact that those who experienced a PI-50 had higher initial scores on the OQ-45 is a
more confusing finding. Hiller et al. (2012) purports that a benefit of the PI-50 criteria in
identifying reliable change is its adjustment to initial severity level: “probably the most
important advantage of the PI method that response requires more improvement (as compared to
using the RCI) in severely ill persons than in those with only mild or moderate signs of
psychopathology” (p. 8). Using this reasoning would suggest that those who have higher distress
levels would be less likely to experience a PI-50, but the opposite is seen in this study.
However, one possible explanation is that of the number of clients who experienced a PI50 was a more conservative sample of the unexpected dramatic treatment response phenomenon
due to criteria 2 in the PI-50 methodology. This criterion requires a change of 25% of the entire
range of the scale to qualify. It is strictly in place to discourage false positive identification of
those clients near the cutoff line of being significantly distressed on the outcome measure to be
able to improve a few points and qualify as experiencing a PI-50 by meeting the 50% reduction
criteria between their initial score and score on the session measured. As a side-effect, this
second PI-50 criteria may lead sampling of those who experienced a PI-50 to be higher in
reported initial severity by excluding those whose initial OQ-45 were close to the cutoff line for
being clinically distressed. Overall, this may be an indication that the PI-50 methodology seems
to be much more sensitive to particular scaling of the outcome measure used in its calculation
likely because of its use of percentages for calculating its criteria and the arbitrary choice to use
“50%”.
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End of treatment distress. Differences were also seen in end of treatment distress
scores between those who experienced each of the phenomena. Interestingly, experiencing any
of the three phenomena predicted lower end of treatment distress levels in the regression
analysis, even after controlling for initial OQ-45 scores. When comparing the eight different
independent combination groups of SG, RR, and PI-50, only two populations emerged:
population one contained clients who experienced none of the phenomenon and clients who
experienced only a RR and not a SG or PI-50. Population two contained any clients who
experienced any combination of RR, SG or PI-50. In addition, when examining the regression
analysis, having experienced a PI-50 or SG was worth over twice as much in reduction of end of
treatment distress as compared to RR. Those who experienced all three phenomena had the
lowest mean end of treatment distress levels (at the mean of the non-dysfunctional normative
sample) and all groups in population two did not differ from one another in this aspect.
One possible explanation of this may be the sample size of the two groups. Both the
group of individuals who experienced none of the phenomenon and those who experienced only
a RR were considerably larger than the other six independent groups. As the number of clients
who experienced a RR was much higher than the other phenomena, it may be that the RR
methodology is a more liberal assessment of unexpected dramatic treatment response,
encompassing a wider swath of individuals than the other two phenomena, with the effects on
end of treatment distress are much closer to the overall population mean.
Nevertheless, this discrepancy suggests that when using RR as a predictive tool, it is
more likely for a client to experience a RR in the sample, but less reliable about predicting
significant differences in end of treatment distress scores, especially when the RR does not cooccur with one of the other phenomena. This again offers more evidence that SG, PI-50, and RR
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phenomena are significantly different from one another in important aspects that will be key to
its future uses as a clinical feedback and research tool for unexpected dramatic treatment
response.
Total change. Differences were seen in total change on the OQ-45 between those who
experienced any combination of SG, RR, and PI-50 and the rest of the population. This
difference was large and the distance between the mean of those who experienced none of the
three phenomena (9.82) and those who experienced a RR only and not a SG or PI-50 (12.70), the
next highest of the eight independent groups, was over 14 OQ-45 points. Further, when
accounting for beginning OQ-45 scores, the baseline total change score is reduced to below 4
OQ-45 points (3.81) in the regression model, indicating that experiencing any of these
phenomena has a significant additive effect on the total change that occurs during treatment even
when accounting for beginning distress levels. In the analysis, true additive effects are seen in
that generally the larger the amount of total change, the more of these phenomena that were
experienced in combination with one another. Consequently, those who experienced a SG, RR,
and PI-50 experienced on average over 57 points in change on the OQ-45 (see Figure 1 in
results above) as opposed to the 9.82 points of change experienced by those who did not
experience any of the phenomena, a difference of over 47 points.
It is notable that according to the regression model, experiencing a PI-50 was worth more
than double additional points on the OQ-45 over the group mean for total change when
compared to a RR (28.16 vs 12.71). This may challenge the notion that early occurrence of the
change is required for prediction of the largest improvement during therapy as both RR and PI50 in this analysis had to occur in the first three sessions of treatment to be included. However,
it should be noted the PI-50 criteria again is the most exclusive of the three methodologies
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studied, identified the least amount of clients, and started treatment with the highest distress
scores. Further studies may need to examine if the restrictive nature of PI-50 methodology is
correlated to higher amounts of change over the course of treatment in those who experience a
PI-50.
Dosage statistics. With only a few exceptions, a high amount of overlap was found
between those who experienced a SG, RR, and PI-50 and those experienced none of the
phenomena on the number of weeks in treatment and in the number of sessions attended. This
was particularly true of independent groups containing some combination of experiencing a PI50 or RR phenomenon. This offers some further evidence that dropping out of therapy may not
be an accurate indicator of treatment failure, as those who experienced RR and PI-50 had much
higher recovery rates than the overall population mean, despite receiving a similar dosage of
treatment.
However, the analysis models that were run did note that experiencing any of the
phenomena study was associated with differences in weeks in treatment and sessions attended.
This outcome likely has to do with those who experienced a SG and not a PI-50 or RR. This
independent group attended far more weeks of treatment compared to clients who experienced
some combination of a RR or PI-50. This may be indicative of the difference between SG and
the other two phenomena’s requirement to occur “early” in treatment. Further, in the regression
model, experiencing a RR or PI-50 was associated with number of weeks in treatment and
sessions attended that were similar or significantly less than the overall group mean. In contrast,
experiencing a SG was worth an additional 49 weeks in treatment or attending over 12 additional
sessions. Interestingly, those who experienced a SG in combination with either a RR or PI-50
did not differ on post hoc analysis from the other groups in weeks in treatment or sessions
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attended; further evidence on the contrast between “early” criteria of RR and PI-50 with SG
ability to occur throughout treatment.
Considering the session restriction in the PI-50 and RR phenomena criteria stating that
they needed to occur in the first three sessions of treatment, experiencing either a PI-50 or RR
may be associated with dropping out sooner from therapy than those who experience a SG.
Indeed we know from other research that after experiencing clinically significant change, clients
tend to drop out of treatment (Kadera, Lambert, & Andrews, 1996). Thus, while experiencing a
SG in this study is still predictive of high recovery rates, many clients who experience them may
be in treatment longer and for more sessions until they experience the SG, their distress levels
lower considerably, and then treatment is discontinued.
Use of RR and SG in Examining Treatment Components
SG, RR, and PI-50 may be used to examine effectiveness of treatment components, but
their effectiveness in doing so may not overlap as many differences were seen between
phenomena. Of particular note, the SG method seem to be used in past research to attempt to
fully examine effective or causal treatment components that lead to unexpected dramatic
response. This may be due to unique identification tool of SG vs PI-50 or RR. Whereas the
latter two phenomena’s criteria are based upon initial distress score and deviation therefrom, the
SG criteria focuses on unexpected dramatic change in a single intersession period. While this
intersession period occurs more often early in therapy, it can and has been observed, including in
this study, to occur throughout therapy.
Further, in SG literature SG have been repeatedly used in an effort to try and offer
evidence of cognitive change or other treatment components positively effecting treatment
components (Aderka et al., 2012). As such, Aderka et al. (2012), Tang and DeRubeis (1999b),
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and others have theorized the single intercession period measured in a SG capture the beginning
of an “upward spiral” positive feedback loop of behavioral changes in the client signifying
improvement. Others have purported SG as part of gradual change pattern leading to positive
outcomes regardless of the techniques that are offered (Thomas & Persons, 2013). In
summation, that SG criteria focus on a single intercession period may make it more appropriate
for use at studying effective treatment components.
Evidence of this flexibility may be seen in this study in that those who experience a SG
are much more likely to be in treatment longer or attend more sessions but still have a similarly
high recovery rate. Further, in our secondary analysis we saw higher but still only about 50%
overlap between clients who experienced a SG and a RR any time in therapy. As such, this
offers evidence of some utility of SG over RR in studying these specific periods of time where
unexpected dramatic improvement occurs from one session to the next and is associated with
high recovery rates.
In contrast, both RR and PI-50 occur so early in the treatment process that by definition
they may precede any theoretical component that may contribute to change (Haas et al., 2002).
Further, Lambert (2005) cites RR research among other research occurrences of “early”
unexpected dramatic treatment response at challenging the need for specific components of
therapy and suggests that RR may be indicative of the power of common factors or client factors
in successful treatment process and outcome. The RR phenomon is based on outperforming
other clients with identical initial OQ-45 scores. Thus, RR may allow comparison of these client
characteristics that may contribute to high recovery rates which may be present in those who
experience a RR when they begin treatment and before treatment components can take effect.
Regardless, it is clear that PI-50 and RR, when observed in the first three sessions of therapy, are
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predictive of success despite lack of theoretical underpinnings to explain their existence as a
predictive phenomenon. Further research in this area may lead to increased knowledge of what
makes a successful therapeutic process aside from treatment components.
Limitations
While many of the findings and associated characteristics of those who experience a PI50, RR, and SG are similar to past studies, a main component of difference between this and
historical studies was the low occurrence of the phenomena in the overall sample. Of the overall
sample, 6.6% experienced a SG. This is significantly lower than historical SG studies that use an
RCT format and even lower (6.6% vs 17.8%) than Stiles et al. (2003), a SG study that examined
a non-RTC community sample and used a similar general distress measure. Likewise,
comparing those who experienced a PI-50 in this study with our historical example (Renaud et
al., 1998), we see that our study identified a dramatically smaller portion of the clients as having
experienced a PI-50 (1.7% vs 31.0%). However, Renaud et al. (1998) is an example of an RCT
study that only included clients who met depression criteria as opposed to our clinically
distressed but diagnosis non-verified sample. Lastly, those who experienced a RR were the most
identified out of any portion of the sample (12.0 %) but still less than when looking at the
historical study the criteria was based upon that used a similar ITT outpatient university
population (Haas et al., 2002).
These differences in occurrence rate may be associated with differences in populations of
clients used for previous studies. Of the SG studies reviewed above, none looked at a college
counseling center setting. Similarly the PI-50 studies reviewed were conducted in either ITT
controlled outpatient research settings (Hiller et al., 2012) or an RCT for treatment of adolescents
(Renaud et al., 1998). However, this study used a college counseling center data. Previous work
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done by Lambert et al. (2011) demonstrated that once low scoring non-clinical clients are
removed, as they were for this study, it represents the same level of disturbance found in
outpatient therapy and clinical trials. As such, while the clients for this study may have unique,
unknown characteristics of treatment that contribute to the considerably lower occurrence rates
than historical studies, it most likely represents a typical large ITT outpatient sample.
One may suspect that another limitation of this study may be seen in the adaptation of
these phenomena for use with the OQ-45. However, this limitation may not hold weight as the
SG was originally tested for use with the BDI (Tang & DeRubeis, 1999b) and also shown use
with the CORE inventory (Stiles et al., 2003); both measures which has been shown to have a
high correlation with the OQ-45 (Lambert et al., 2011). Further the PI-50 was originally used
with the Hamilton Depression scale but later adapted for use with the BDI (Hiller et al., 2012).
So, while it is possible that some of the unique characteristics seen about each phenomenon in
this study may be due to an adaptation of SG and PI-50 criteria to measures that they were not
originally tested with the high correlation between measures likely eliminates most of this
variance.
However, some concern with the PI-50 methodology exists due to its use of simple
percentages of the OQ-45 distress scale are used in calculation. For comparison the BDI has a
range with a top maximum at 60 with scores 14 and over in the clinical range offering a 46 point
span of which the PI-50 percentages are taken. Conversely, the OQ-45 starts the clinical range at
64 and goes up to 180 offering a clinical range of 116 points. However, most OQ-45 scores fall
below 100. As a result, Hiller et al. (2012) and others have noted, that the PI-50 method is likely
more sensitive to the unique characteristics of the outcome measure used and that comparisons of
PI-50 scores across measures should be interpreted with caution.
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RR, as conceptualized in this study, was originally tested for use with the OQ-45.
Therefore, we may expect that this is likely not a limitation of the RR method.
Some might also consider the use of a naturalistic sample to be a limitation of this study.
It is true that some limitations of this dataset may be present, especially in the area of
background information and diagnosis. However, caution is warranted against only studying any
unexpected dramatic treatment responses in RTC or completer samples. When discussing the
concept of those who respond to therapy quickly and dramatically, Haas et al. (2002) stated the
following,
Unfortunately studying only patients who have longer treatment durations could result in
missing the phenomenon because in routine clinical practice (as opposed to clinical trials
research) patients tend to drop out of treatment soon after reaching criteria for clinically
significant change (Kadera et al., 1996). Thus, examining only longer treatment
durations would mean studying a preponderance of patients who do not show an early
treatment response.
Further, one future use of SG, RR, or PI-50 methodology may be to use the presence of
the phenomenon as a predictive tool of good outcomes or a feedback tool for clients or
clinicians. As such, restriction to only RTC settings may give unrealistic expectations of its
functionality in most clinical settings.
Conclusion
In summation, this study suggests that there are significant differences between SG, RR,
and PI-50 as methods for operationally defining unexpected dramatic treatment response, caution
should be used when referring to SG, PI-50, and RR as the same phenomenon or interchangeable
terms for unexpected dramatic treatment response. Experiencing any of the three phenomenon
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was associated with higher recovery rates than the population norm despite their theoretical and
methodological differences. While all three methods identify clients who are likely to have high
recovery rates, differences abound in both which clients experience each of the phenomena and
demographic characteristics of those clients.
Experiencing a PI-50 seemed to predict the highest recovery rates, highest starting
distress score, and largest total change during treatment while also reflecting the lowest weeks in
treatment, sessions attended, and end of treatment OQ-45 scores, but it identified only a small,
even trivial, number of clients. In contrast, those who met criteria for a RR were associated with
moderate recovery rates and end of treatment OQ-45 scores but identified substantially more
clients who went on to recover. Lastly, SG demonstrated a strong tie to high recovery rates but
included clients all throughout the treatment process rather than just in the first three sessions.
Clients who experienced a SG were on average in treatment for significantly longer amounts of
time, attended more sessions and did not differ from the overall group mean on starting distress
scores. The SG and RR methods identified significantly more clients than the PI-50 method,
which may limit the PI-50 methods usability as a prediction feedback tool. When comparing
those who experience a RR any time throughout treatment instead of just the first three sessions,
overlap in percentage of “recovered” clients identified is higher, but not 100%, with “recovered”
clients who experience a SG signifying significant differences between RR and SG.
These results tying SG, RR, and PI-50 to significant rates of recovery and positive
treatment change suggest possible future use as a predictive feedback tool for clients and
clinicians alike to be better able to examine the effectiveness of treatment components during
treatment. As such, clinicians looking for a predictive tool during treatment who observe either a
SG, RR, or PI-50 in their clients may be able to use the presence of the phenomenon as an
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indication of a higher likelihood of positive treatment outcomes. As predictive tools have
become more commonly pursued by researchers in an effort to give clinicians predictions of
treatment outcome (Newnham & Page, 2010) and evidence continues to mount suggesting that
they can be effective in providing useful feedback in other contexts such as predicting negative
treatment outcomes (Shimokawa et al., 2010), the exploration of use of RR, PI-50, and SG as
predictive methods becomes more relevant. Further, RR, PI-50, and SG phenomena can be
calculated and identified during the course of treatment and easily calculated by hand or by being
built into the software of the measure being used to track treatment progress. This will likely
help clinicians identify clients who have unexpected dramatic change in real time, while helping
reduce human error that has been observed in past studies that ask clinician to identify clients
who experience these phenomena (Davies et al., 2006). Evidence in this study offers preliminary
hope that further research in use of SG, RR, and PI-50 in this predictive manner may be fruitful
in increasing treatment effectiveness.
SG, RR, and PI-50 may be used to examine effectiveness of treatment components, but
their effectiveness in doing so may not overlap as many differences were seen between
phenomena. SG may be more appropriate for examining treatment components whereas RR
challenges the notion that treatment components are necessary to experience an unexpected
dramatic response and high recovery rates. As such, further research exploring the etiology of
these phenomena and the validity of some of the more arbitrary criteria may help clinicians
understand how to facilitate more unexpected dramatic treatment response to occur and as such
improve treatment outcomes. Further, future research about what causes unexpected dramatic
change to occur and what client characteristics may also contribute to future improvements in
mental health treatment and the understanding of the mechanisms of change in psychotherapy.
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